Abstract
Pulmonary lymphangioleiomyomatosis (LAM) is rare. Its cause is not known, and it principally affects women during the childbearing years. LAM occurs sporadically (not as an inherited disease) or it can be one manifestation of tuberous sclerosis (one third of patients have LAM), which is an inheritable multiorgan hamartomatosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Glassberg M. Lymphangioleiomyomatosis. Clin Chest Med 2004;25:573–582.
Evans S, Colby T, Ryu T, Limper A. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis. Chest 2004;125:1063–1070.
O’Brien J, Lium J, Parosa J, Deyoung B, Wick W, Trulock E. Lymphangioleiomyomatosis recurrence in the allograft after single-lung transplantation. Am J Respir Crit Care Med 1995;151:2033–2036.
Tanaka H, Imada A, Morikawa T, Shibusa T, Satoh M, Sekine K, Abe S. Diagnosis of pulmonary lymphangioleiomyomatosis by HMB45 in surgically treated pneumothorax. Eur Respir J 1995;8:1879–1882.
Kitaichi M, Izumi T. Lymphangioleiomyomatosis. Curr Opin Pulm Med 1995;1:417–424.
Ryu JH, Swensen SJ. Cystic and cavitary lung diseases: Focal and diffuse. Mayo Clin Proc 2003;78:744–752.
Rights and permissions
Copyright information
© 2006 Springer-Verlag London Limited
About this chapter
Cite this chapter
(2006). Lymphangioleiomyomatosis. In: Clinical Atlas of Interstitial Lung Disease. Springer, London. https://doi.org/10.1007/978-1-84628-326-0_32
Download citation
DOI: https://doi.org/10.1007/978-1-84628-326-0_32
Publisher Name: Springer, London
Print ISBN: 978-1-84628-320-8
Online ISBN: 978-1-84628-326-0
eBook Packages: MedicineMedicine (R0)